Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 467
Immune Disorders Drugs 194
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 124
Drug Discovery 107
Central Nervous System Drugs 106
Endocrine and Metabolic Disorders Drugs 103
Clinical Trials 98
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 89
Leukemia Drugs 83
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 33
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 26
Analgesics 26
Drugs by Therapeutic Area 24
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Prostate Cancer Drugs 17
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,397 Results (Page 11 of 120)
- Relevance
  Sort by

Follicular Thyroid Cancer Drugs Market - Global Strategic Business Report

 Report
December 2025
278 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Glioblastoma Multiforme Treatment Market Report by Drug Type, and Region 2025-2033

 Report
August 2025
138 Pages
Global

From

€2246EUR$2,549USD£1,973GBP

€2643EUR$2,999USD£2,321GBP

Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report

 Report
December 2025
196 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Colorectal Cancer Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Chemotherapy, Immunotherapy), By Region (North America, Asia Pacific, Latin America, Europe), And Segment Forecasts, 2023 - 2030

 Report
September 2023
100 Pages
Global

From

€5243EUR$5,950USD£4,605GBP

Muscle-invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
321 Pages
Global

€4402EUR$4,995USD£3,866GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

United States Endometrial Cancer Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
90 Pages
United States

From

€3084EUR$3,500USD£2,709GBP

Brain Cancer Drugs Market - Global Forecast 2025-2032

 Report
November 2025
188 Pages
Global

From

€3124EUR$3,545USD£2,744GBP

€3471EUR$3,939USD£3,049GBP

Brain Tumor Therapeutics Market - Global Forecast 2025-2032

 Report
October 2025
191 Pages
Global

From

€3124EUR$3,545USD£2,744GBP

€3471EUR$3,939USD£3,049GBP

Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
734 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

Schizophrenia Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

 Report
April 2025
200 Pages
Global

From

€2194EUR$2,490USD£1,927GBP

Schizophrenia Therapeutics Market - Global Forecast 2025-2032

 Report
November 2025
185 Pages
Global

From

€3124EUR$3,545USD£2,744GBP

€3471EUR$3,939USD£3,049GBP

Leukemia Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

 Report
April 2023
120 Pages
Global

From

€4186EUR$4,750USD£3,677GBP

Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
359 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

Brain & Spinal Cord Cancer Market - Global Forecast 2025-2032

 Report
October 2025
181 Pages
Global

From

€3124EUR$3,545USD£2,744GBP

€3471EUR$3,939USD£3,049GBP

Glioma Treatment Market - Global Forecast 2025-2032

 Report
November 2025
189 Pages
Global

From

€3124EUR$3,545USD£2,744GBP

€3471EUR$3,939USD£3,049GBP

Gardner Syndrome Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3957EUR$4,490USD£3,475GBP

Licensing Deals in Pharmaceuticals 2020-2025

 Report
September 2025
1000 Pages
Global

From

€4402EUR$4,995USD£3,866GBP

Antimicrobial Therapeutics Market - Global Strategic Business Report

 Report
December 2025
494 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Cephalosporin Drugs - Global Strategic Business Report

 Report
December 2025
398 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Muscle Invasive Bladder Cancer- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1057EUR$1,200USD£929GBP

€1322EUR$1,500USD£1,161GBP

2,397 Results (Page 11 of 120)
- 1
- 9
- 10
- 11
- 12
- 13

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.